RE: France27 Aug 2020 13:26
no worries oakK, its worthy of repeating :)
Usain, it's doesn't mention how many gene targets for influenza. Not sure if it's singular gene for each type or if it's targeting more than one gene.
On 27 July 2020, Novacyt announced the development of a respiratory test panel, which includes its high-performance COVID-19 PCR test. The Winterplex™ test panel includes two gene targets specific to COVID-19, as well as gene targets for influenza A&B and respiratory syncytial virus (RSV). Clinical trial data demonstrated 100% specificity and between 96% and 100% sensitivity across the panel.
Its a one stop test for healthcare professionals to understand what virus they are dealing with. Very useful!